# Viking Therapeutics, Inc (VKTX)

Viking Therapeutics' oral VK2735 advances to Phase 3, sparking acquisition speculation amidst positive clinical data and competitive positioning in the growing obesity market.

### About Viking Therapeutics, Inc
Viking Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for metabolic and endocrine disorders.  
Viking Therapeutics, Inc uses the ticker $VKTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Viking Therapeutics, Inc (VKTX) social dominance hit [------] which is 387% higher than it's daily average.
- Viking Therapeutics, Inc (VKTX) trading volume is up 23.28% from the previous week.
- Viking Therapeutics, Inc (VKTX) social dominance is up 494.26% from the previous month.
- Viking Therapeutics, Inc (VKTX) creators is up 84.45% from the previous week.
- Viking Therapeutics, Inc (VKTX) engagements is up 55.81% from the previous week.
- Viking Therapeutics, Inc (VKTX) mentions is up 51.37% from the previous month.
- Viking Therapeutics, Inc (VKTX) posts created is up 86.45% from the previous week.

### Price: $29
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/close.tsv)  
The current price is down due to recent negative price action and valuation concerns, compounded by the launch of Novo Nordisk's oral weight-loss pill and insider selling, despite positive sentiment from acquisition speculation and clinical data.  

24-Hour: -4.07%
7-Day: 1.19%
30-Day: -14.5%

1-Year High: $42.10 on 2025-08-18  
1-Year Low: $20 on 2025-04-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/alt_rank.tsv)  
Viking Therapeutics, Inc (VKTX) is currently AltRank #415 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] [----]  
[--] Month: [---] +262  
[--] Months: [---] +360  
[--] Year: [---] +300  
1-Year High: [-----] on 2025-07-06  
1-Year Low: [--] on 2025-02-22  
  
  
### Galaxy Score: [--]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/galaxy_score.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +4  
[--] Month: [--] +24  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-04-29  
1-Year Low: [--] on 2025-02-25  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [-------]  
[--] Week: [---------] +56%  
[--] Month: [---------] -3.80%  
[--] Months: [----------] -19%  
[--] Year: [----------] -51%  
1-Year High: [---------] on 2025-08-19  
1-Year Low: [------] on 2026-02-15  

Engagements by network (24h):
News: [--]
TikTok: [--]
X: [------]
YouTube: [---]
Reddit: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [-----] +48%  
[--] Month: [-----] +51%  
[--] Months: [------] -22%  
[--] Year: [------] -45%  
1-Year High: [-----] on 2025-08-20  
1-Year Low: [---] on 2025-12-21  

Mentions by network (24h):
News: [--]
TikTok: [--]
X: [---]
YouTube: [--]
Reddit: [--]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Viking Therapeutics, Inc (VKTX) in the last [--] hours which is down 26% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] +84%  
[--] Month: [-----] +58%  
[--] Months: [-----] -12%  
[--] Year: [-----] +6.80%  
1-Year High: [---] on 2025-08-20  
1-Year Low: [--] on 2025-09-15  

The most influential creators that mention Viking Therapeutics, Inc in the last [--] hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@semodough](/creator/twitter/semodough)           | [--]    | [-----]     | [--]    | [-----]       |
| [@jayabacus](/creator/twitter/jayabacus)           | [--]    | [-----]     | [--]     | [-----]       |
| [@Pharmdca](/creator/twitter/Pharmdca)             | [--]    | [-------]   | [--]    | [-----]       |
| [@BioStocks](/creator/twitter/BioStocks)           | [--]    | [------]    | [--]     | [-----]       |
| [@danielnewmanUV](/creator/twitter/danielnewmanUV) | [--]    | [------]    | [--]     | [-----]       |
| [@ResearchPulse1](/creator/twitter/ResearchPulse1) | [--]    | [-----]     | [--]    | [-----]       |
| [@semodough](/creator/twitter/semodough)           | [--]    | [------]    | [--]    | [-----]       |
| [@Alpha_bro1](/creator/twitter/Alpha_bro1)         | [--]    | [---]       | [--]    | [-----]       |
| [@RolfHattesen](/creator/twitter/RolfHattesen)     | [--]    | [--]        | [--]     | [-----]       |
| [@ASchulz888](/creator/twitter/ASchulz888)         | [--]   | [-----]     | [--]     | [---]         |

[View More](/list/creators/$vktx/100)
  
  
### Sentiment: 82%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/sentiment.tsv)  
Current Value: 82%  
Daily Average: 74%  
[--] Week: 77% +4%  
[--] Month: 92% +28%  
[--] Months: 92% +32%  
[--] Year: 92% +29%  
1-Year High: 93% on 2025-04-26  
1-Year Low: 53% on 2026-02-01  

Most Supportive Themes:
- Acquisition Speculation: (45%) Viking Therapeutics is being considered a potential acquisition target by larger pharmaceutical companies.
- Positive Clinical Data and Market Growth: (30%) The company's obesity drug, VK2735, has shown promising Phase [--] data, contributing to optimism in the growing obesity treatment market.
- Competitive Positioning: (15%) Viking Therapeutics is viewed as a strong competitor in the obesity market, with comparisons drawn to major players like Lilly and Novo Nordisk.
  
Most Critical Themes:
- Valuation Concerns: (10%) Some market participants question Viking Therapeutics' current valuation, suggesting it may not fully justify a high buyout price based on Phase [--] data.
  
  
  
### Social Dominance: 0.055%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/social_dominance.tsv)  
Current Value: 0.055%  
Daily Average: 0.096%  
[--] Week: 0.107% +0.069%  
[--] Month: 0.466% +0.387%  
[--] Months: 0.466% +0.309%  
[--] Year: 0.466% +0.289%  
1-Year High: 0.466% on 2026-02-15  
1-Year Low: 0.03% on 2025-12-21  
  
  
### Market Dominance: 0.00383%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/market_dominance.tsv)  
Current Value: 0.00383%  
Daily Average: 0%  
1-Year High: 0.154% on 2026-02-12  
1-Year Low: 0.00383% on 2026-02-14  
  
  
### Market Cap: $3,379,963,129
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$vktx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$vktx/time-series/market_cap.tsv)  
Current Value: $3,379,963,129  
Daily Average: $3,442,223,640  
[--] Week: $3,379,963,129 +5.70%  
[--] Month: $3,351,074,555 -7%  
[--] Months: $3,351,074,555 -29%  
[--] Year: $3,351,074,555 -1.50%  
1-Year High: $4,732,808,408 on 2025-08-18  
1-Year Low: $2,243,529,405 on 2025-04-08  

### Top Viking Therapeutics, Inc Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"@andyroyle_pwrc For Oral $VKTX for sure will be pharma number [--]. For injection they should be number [--] too but I think but it will be a tight race with Amgen. And Amgen is more a niche player (monthly) with an inferior drug"  
[X Link](https://x.com/Alpha_bro1/status/2022809575703904258) [@Alpha_bro1](/creator/x/Alpha_bro1) 2026-02-14T23:05Z [---] followers, [---] engagements


"@breakoutchrts @Keith_Simonian Its doable but $VKTX probably shouldnt do it alone. Reducing peptide costs per mg at scale demands massive capex billions. and they need a huge sales team. It won't be efficient. $ABBV looks like a great partner unless $NVO steps up"  
[X Link](https://x.com/Alpha_bro1/status/2022804138854101463) [@Alpha_bro1](/creator/x/Alpha_bro1) 2026-02-14T22:44Z [---] followers, [---] engagements


"They already exhausted FMR and a few other $VKTX institutions that get there on rumors and flash trial results. CEO is not helping in this regard as can burn shorts with an update on vanquish comparison to competitors etc. he seems very relaxed . may he seeing level of interest that we dont see . All doesnt matter even short term as $NVO $ABBV $BMY and probably $MRK reaching stress level to get a dual agonist"  
[X Link](https://x.com/bioinvestor24/status/2022781015501259192) [@bioinvestor24](/creator/x/bioinvestor24) 2026-02-14T21:12Z [----] followers, [---] engagements


"@jayabacus The truth is that rybelsus/wegovy pill isn't that good in the real world. It's a stellar opportunity for $vktx and lilly tbf"  
[X Link](https://x.com/R9Falcone/status/2022705222041083911) [@R9Falcone](/creator/x/R9Falcone) 2026-02-14T16:11Z [---] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing